Calidi Biotherapeutics Statistics
Total Valuation
CLDI has a market cap or net worth of $11.30 million. The enterprise value is $21.87 million.
Market Cap | 11.30M |
Enterprise Value | 21.87M |
Important Dates
The next estimated earnings date is Monday, August 19, 2024, before market open.
Earnings Date | Aug 19, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
CLDI has 6.42 million shares outstanding. The number of shares has increased by 310.77% in one year.
Shares Outstanding | 6.42M |
Shares Change (YoY) | +310.77% |
Shares Change (QoQ) | +110.53% |
Owned by Insiders (%) | 47.63% |
Owned by Institutions (%) | 5.35% |
Float | 21.75M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | n/a |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.13
Current Ratio | 0.13 |
Quick Ratio | n/a |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -39.11 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -259.60% |
Return on Capital (ROIC) | n/a |
Revenue Per Employee | n/a |
Profits Per Employee | -$731,195 |
Employee Count | 41 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
In the past 12 months, CLDI has paid $16,000 in taxes.
Income Tax | 16,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -98.33% in the last 52 weeks. The beta is 0.42, so CLDI's price volatility has been lower than the market average.
Beta (5Y) | 0.42 |
52-Week Price Change | -98.33% |
50-Day Moving Average | 2.08 |
200-Day Moving Average | 10.44 |
Relative Strength Index (RSI) | 46.32 |
Average Volume (20 Days) | 210,094 |
Short Selling Information
The latest short interest is 55,247, so 0.86% of the outstanding shares have been sold short.
Short Interest | 55,247 |
Short Previous Month | 22,839 |
Short % of Shares Out | 0.86% |
Short % of Float | 0.25% |
Short Ratio (days to cover) | 0.31 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -30.33M |
Pretax Income | -29.96M |
Net Income | -29.98M |
EBITDA | -27.77M |
EBIT | -29.22M |
Earnings Per Share (EPS) | -$6.90 |
Balance Sheet
The company has $1.14 million in cash and $11.71 million in debt, giving a net cash position of -$10.57 million or -$1.65 per share.
Cash & Cash Equivalents | 1.14M |
Total Debt | 11.71M |
Net Cash | -10.57M |
Net Cash Per Share | -$1.65 |
Equity (Book Value) | -14.57M |
Book Value Per Share | -2.27 |
Working Capital | -13.02M |
Cash Flow
In the last 12 months, operating cash flow was -$27.71 million and capital expenditures -$453,000, giving a free cash flow of -$28.16 million.
Operating Cash Flow | -27.71M |
Capital Expenditures | -453,000 |
Free Cash Flow | -28.16M |
FCF Per Share | -$7.92 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
CLDI does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -310.77% |
Shareholder Yield | -310.77% |
Earnings Yield | -265.36% |
FCF Yield | -249.26% |
Analyst Forecast
The average price target for CLDI is $1.67, which is -5.11% lower than the current price. The consensus rating is "Strong Buy".
Price Target | $1.67 |
Price Target Difference | -5.11% |
Analyst Consensus | Strong Buy |
Analyst Count | 3 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |